Atlas Trials

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Clinical trial NCT00349193 · COMPLETED

Trial details

NCT number
NCT00349193
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2005-03-01
Primary completion
2006-06-01
Enrollment
306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.